Analytes/procedures in
bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
This program assesses the laboratory’s ability to detect p16 overexpression in squamous cell carcinomas, mainly as a surrogate for HR-HPV detection in head and neck tumors.
Program Information
- One 10‑core tissue microarray slide
Shipping Schedule
-
Shipment A: April 8
-
Shipment B: November 11